ACC.24 - Can treatment with the selective aldose reductase inhibitor AT-001 prevent deterioration of exercise capacity and the onset of HF in patients with diabetic cardiomyopathy? James Januzzi shares the results of ARISE-HF.
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
ACC.24 - Can treatment with the selective aldose reductase inhibitor AT-001 prevent deterioration of exercise capacity and the onset of HF in patients with diabetic cardiomyopathy? James Januzzi shares the results of ARISE-HF.
This video was recorded in response to a presentation at the Congress of the American College of Cardiology (ACC) 2024.
James Januzzi is the Adolph Hutter Professor of Medicine at Harvard Medical School, Boston, MA, US. He also is the Director of Heart Failure Clinical Trials at the Baim Institute for Clinical Research, a staff cardiologist at the Massachusetts General Hospital, and a Trustee of the American College of Cardiology.
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Release date: 23 April 2024
ACC.24 - Can treatment with the selective aldose reductase inhibitor AT-001 prevent deterioration of exercise capacity and the onset of HF in patients with diabetic cardiomyopathy? James Januzzi shares the results of ARISE-HF.
This video was recorded in response to a presentation at the Congress of the American College of Cardiology (ACC) 2024.
James Januzzi is the Adolph Hutter Professor of Medicine at Harvard Medical School, Boston, MA, US. He also is the Director of Heart Failure Clinical Trials at the Baim Institute for Clinical Research, a staff cardiologist at the Massachusetts General Hospital, and a Trustee of the American College of Cardiology.
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Release date: 23 April 2024
Stay current with the best on medical education
